Interaction between trazodone and carbamazepine

Annals of Pharmacotherapy

Volumn 33, Issue 12, 1999, Pages 1370-

  Romero, Alberto Sánchez ^a   García Delgado, Rafael ^b   Peña, Mario Flores ^c  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

^b Clinical Pharmacology Service   (United States)

^c Psychiatrist Psychiatry Service   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; TRAZODONE;

ADULT; CASE REPORT; DEPRESSION; DOSE RESPONSE; DRUG ELIMINATION; DRUG MECHANISM; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HUMAN; LETTER; MALE; PRIORITY JOURNAL;

ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CARBAMAZEPINE; DEPRESSIVE DISORDER; EPILEPSY, COMPLEX PARTIAL; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMANS; MIDDLE AGED; TRAZODONE;

EID: 84992813108     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1345/aph.19030     Document Type: Letter

References (5)

1. Lanchote VL, Bonato PS, Campos GM, Rodrigues I. Factors influencing plasma concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic children and adults. Ther Drag Monit 1995;17:47–52.
2. Anderson GD. A mechanistic approach to antiepileptic drug interactions. Ann Pharmacother 1998;32:554–63.
3. Kerr BM, Thummel KE, Wurden CJ, Klein SM, Kroecz DL, Gonzalez F, et al. Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation. Biochem Pharmacol 1994;47:1969–79.
4. Greene DS, Barbhaiya RH. Clinical pharmacokinetics of nefazodone. Clin Pharmacokinet 1997;33:260–75.
5. Ashton AK, Wolin RE. Nefazodone-induced carbamazepine toxicity (letter). Am J Psychiatry 1996;153:733.